Blog

Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace

12 June 2019 Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been there: Eli Lilly, ICI Australia, CSL Limited,…

New Business Growth Fund to Create Jobs

7 June 2019 The Andrews Labor Government will establish a $250 million Victorian Business Growth Fund for small and medium enterprises to help them access capital and create jobs to grow the Victorian economy. Treasurer Tim Pallas today…

SCHOTT AG to acquire Australian microfluidic expert MINIFAB

5 June 2019 Customers to benefit from complementary portfolio of top quality polymer and glass solutions for breakthrough diagnostics applications SCHOTT AG, a leading international technology group in the areas of specialty glass and glass-ceramics, has entered into…

Proactive Investors interviews CEO Sam Cobb on recent placement

5 June 2019 We are pleased to share the recent video recording of CEO, Sam Cobb in discussion with Proactive Investors. Sam provided further insight into the successful completion of a $5 million Placement announced last week, and…

LBT $5M Oversubscribed Private Placement

5 June 2019 I’m pleased to announce today the successful capital raise of ~$5 million through a private placement.  The Company welcomes the new institutional investors to the register and this capital injection to the business is positive…

Potential Cancer Treatment Discovery – SVI

5 June 19 We are pleased to announce that a study undertaken by SVI researchers Associate Professor Andrew Deans and Dr Julienne O’Rourke, in collaboration with the Children’s Medical Research Institute (CMRI) in Sydney, has identified not one,…

Funding Vital Medical Research – Monash Vision Group

Monash Vision Group has received one of the ten $1M MRFF Frontiers grants to commercialise our BMI technologies. This is very exciting as it gives us a 20-40% chance of $100M to $50M Stage 2 funding and the…

ARCS Annual Conference – Putting patients at the centre of healthcare on 6-8 August 2019 at the ICC, Sydney (NSW)

The ARCS Annual Conference is a must attend event for professionals from the medtech, biotech and pharmaceutical sectors at all stages of their careers. This year’s program consists of plenaries and up to seven parallel sessions over three…

National Foundation for Medical Research and Innovation – Alzheimer’s Disease Grant Round now open

2019 Grant Rounds: Alzheimer’s Disease Grant Round – As part of the National Foundation for Medical Research and Innovation’s partnership with The Mason Foundation (managed by Equity Trustees), NFMRI is seeking EOIs for projects investigating potential treatments and/or…

APAS® INDEPENDENCE RECEIVES US FDA 510(k) CLEARANCE

Regulatory clearance of commercial instrument provides access to over 1,500 U.S. laboratories as potential customers Investor call at 9.00am AEST, Tuesday 21 May 2019 to discuss FDA clearance and U.S. market opportunity Adelaide, Australia, 20th May 2019: Australian…

VCCC Investigator-Initiated Trial Building Capability Program: Clinical trials target common symptoms

Monday 20 May 2019 Cancer clinical trials predominantly focus on new therapies to control cancer. However, patients with cancer commonly experience symptoms not directly related to the cancer itself. These symptoms can have a significant impact on the…

MedTech Actuator Announces Collaboration with Johnson & Johnson Innovation to Support Health Tech Startups in Victoria

13 May 2019 A new collaboration is set to strengthen Australia and the Asia Pacific’s innovation ecosystem. The MedTech Actuator has teamed up with Johnson & Johnson Medical Pty Ltd, one of the Johnson & Johnson Medical Devices…

Home

News & opinion

Member Directory

Events